CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

The 106th meeting of the Internal Finance Committee (IFC) of the Central Council for Research in Ayurvedic Sciences (CCRAS) was held at the Regional Ayurveda Research Institute (RARI), Itanagar. The meeting reviewed various ongoing research and development programmes, institutional initiatives, infrastructure development and future priorities of CCRAS aimed at further strengthening scientific research in Ayurveda and allied sciences.

The meeting was chaired by Satyajit Paul, Senior Statistical Advisor, Ministry of Ayush. Professor. (Vaidya) Rabinarayan Acharya, director general, CCRAS and Member Secretary of the Committee, presented the agenda items and apprised the Committee of the Council’s major achievements, key initiatives and significant accomplishments.

The deliberations focused on strengthening research and development activities, institutional capacity, infrastructure and effective implementation of various programmes. The Committee also emphasised the importance of ensuring that advances in Ayurveda research translate into improved healthcare services and wider access to Ayush-based healthcare for the people.

The meeting was attended by Dr. A. Raghu, Advisor, Ministry of Ayush; Dr. Santosh Kumar Bhatted, Professor, All India Institute of Ayurveda; Dr. Vivekanandan Kalaiselvan, secretary-cum-scientific director, Indian Pharmacopoeia Commission; Amrendra Singh, director, IFD; Vijaylakshmi Bhardwaj, director, Ministry of Ayush; Shri Deepak Kochhar, deputy director (administration), CCRAS; and Dr Pratap Makhija, director (Institute), CCRAS, along with senior officials from the Ministry of Ayush and CCRAS.

The Chairperson and Members of the Committee appreciated the progress made by CCRAS, particularly in the areas of research and development and the 100 per cent utilisation of funds during the last financial year.

The meeting concluded with an emphasis on advancing scientific research, strengthening institutional collaboration, ensuring timely implementation of programmes and expanding the reach of Ayush services. The Committee reiterated the importance of translating research outcomes into meaningful benefits for public health and society.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs